Sarbajit Mukherjee
Medical Oncology · Miami, FLNPI 1003164427
Payments from drug & device makers
What this record shows
This record is dominated by education: $200,059 of the $231,683 with a category attached, or 86.4%. Ipsen Biopharmaceuticals, Inc accounts for 86.6% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2020 at $100,150 and has fallen 86.3% since, to $13,680 in 2025. Among medical oncology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 34 payments — averaging $6814.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ipsen Biopharmaceuticals, Inc$201K
- Beone Medicines USA, Inc.$9K
- Beigene USA, Inc.$8K
- E.r. Squibb & Sons, L.L.C.$5K
- Merck$2K
- Eisai Inc.$2K
- plus $4K from 4 others
Across 16 payments — averaging $43,763 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Taiho Oncology, Inc.$611K
- Seagen Inc.$90K
What the payments were for
- Consulting fees$24,01510%
- Travel & lodging$6,5893%
- Food & beverage$1,0200%
- Education$200,05986%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 7 | $200,529 |
| Beone Medicines USA, Inc. | 10 | $9,496 |
| Beigene USA, Inc. | 5 | $7,667 |
| E.r. Squibb & Sons, L.L.C. | 1 | $4,800 |
| Merck | 4 | $2,499 |
| Eisai Inc. | 2 | $2,398 |
| Boehringer Ingelheim International GmbH | 1 | $2,205 |
| Incyte Corporation | 2 | $1,480 |
| Gilead | 1 | $580 |
| Jazz Pharmaceuticals Inc. | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$231,683 in reported general payments places this provider in the 95th percentile of 507 medical oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical oncology in Miami
- Neil LoveMiami$5.6M
- Bruna Pellini FerreiraMiami$158K
- Coral OlazagastiMiami$134K
- Jonathan TrentMiami$102K
- Gilberto LopesMiami$99K
- Craig MoskowitzMiami$94K
- Mahdi TahaBoca Raton$1.7M
- Raji ShameemOrlando$1.3M
- Mohammad JahanzebBoca Raton$1.3M
- Michel VelezOrlando$927K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.